DocumentOpenPublication

Add 8 Viatris Brand Name Change ↓

HealthRef: HP13-2025ARV

Official source

Source domain: health.gov.za

Collected on 14 September 2026

Always confirm details on the official source before acting.

What this means

This document is an addendum to a government pharmaceutical supply contract, confirming an approved brand name change for a specific antiretroviral medicine. It updates the product name from ODINSTI DISPERSIBLE to MYLTEGA 10mg DISPERSIBLE TABLETS under the existing contract. The contract runs from 1 December 2025 to 30 November 2028 and applies to the supplier, Viatris Healthcare (Pty) Ltd.

What this document offers

Read out of this document by Govermate's AI, in its own words. Each one quotes the line it came from — confirm on the official source before acting.

pharmaceutical supply contractOpen

Supply and Delivery of Anti-Retroviral Medicines under Contract HP13-2025ARV

This is a government contract for the supply and delivery of anti-retroviral medicines to the Department of Health, covering the period from 1 December 2025 to 30 November 2028. The contract includes a brand name change for one product from ODINSTI DISPERSIBLE to MYLTEGA 10mg DISPERSIBLE TABLETS.

Who it is for: approved pharmaceutical suppliers with existing contracts with the Department of Health
How to act on it: No action required by external parties; this is an internal contract amendment documented for transparency.
Closes: 30 November 2028

The document's recorded date is 1 December 2025. Confirm on the official source.

Facts

Reference

HP13-2025ARV

Key Takeaways

HP13-2025ARV
01 DECEMBER 2025
30 NOVEMBER 2028
Viatris Healthcare (Pty) Ltd
ODINSTI DISPERSIBLE
MYLTEGA 10mg DISPERSIBLE TABLETS
222001316
Item No 14
Viatris Healthcare (Pty) Ltd
K JAMALOODIEN
Department of Health
Health Products Procurement

Dates

Closing Date (read from the document by Govermate)

30 November 2028

Add 8 Viatris Brand Name Change &darr;